Editorial Open Access
Copyright ©The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Psychiatr. Sep 20, 2018; 8(3): 75-78
Published online Sep 20, 2018. doi: 10.5498/wjp.v8.i3.75
Successful treatment of nightmares may reduce psychotic symptoms in schizophrenia
Mary V Seeman, Department of Psychiatry, University of Toronto, Toronto, ON M5P 3L6, Canada
ORCID number: Mary V Seeman (0000-0001-6797-3382).
Author contributions: Seeman MV is the sole author.
Conflict-of-interest statement: There was no support for this manuscript and no conflict of interest to declare.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Mary V Seeman, DSc, FRCP (C), MD, Emeritus Professor, Department of Psychiatry, University of Toronto, 260 Heath St. W., Suite 605, Toronto, ON M5P 3L6, Canada. mary.seeman@utoronto.ca
Telephone: +1-416-4863456
Received: May 21, 2018
Peer-review started: May 21, 2018
First decision: June 6, 2018
Revised: June 27, 2018
Accepted: June 29, 2018
Article in press: June 29, 2018
Published online: September 20, 2018


Nightmares occur more frequently in patients with schizophrenia than they do in the general population. Nightmares are profoundly distressing and may exacerbate daytime psychotic symptoms and undermine day-to-day function. Clinicians do not often ask about nightmares in the context of psychotic illness and patients may underreport them or, if nightmares are reported, they may be disregarded; it may be assumed that they will disappear with antipsychotic medication and that they do not, therefore, require separate intervention. This is a missed opportunity because Image Rehearsal Therapy, among other psychological and pharmacological interventions, has proven effective for nightmares in non-schizophrenia populations and should be considered at an early stage of psychotic illness as an important adjunct to standard treatment. There is active ongoing research in this field, which will undoubtedly benefit patients with schizophrenia in the future.

Key Words: Sleep, Nightmares, Psychosis, Nightmare-inducing drugs, Image rehearsal therapy

Core tip: A substantial percentage of persons suffering from psychotic illness such as schizophrenia experience frightening nightmares that aggravate their disease symptoms. New treatments for nightmares in the general population are starting to be applied to schizophrenia patients, as are new treatments for other associated sleep problems. This is very promising research that clinicians need to heed, as the lessening of nightmare distress will also help to alleviate daytime psychotic symptoms.


Hearing or imagining malevolent threats is the hallmark of delusions and hallucinations in people with psychotic illness; it is also the stuff of nightmares. The DSM-5 identifies nightmares as being extremely distressing, long-lasting, and well-remembered dreams that involve threats to survival, security, or physical integrity. There are many ways in which the delusions and hallucinations of psychotic illness overlap with the substance of nightmares: in the centrality of the protagonist to the plot of the story line, in the illusion of reality despite improbable circumstances, in the thematic content (persecution, danger, humiliation) and in the resulting emotions[1,2]. Nightmares can be conceptualized as forming part of the ego disorders that lead to “bizarre” or unreal delusions, considered by Bleuler as fundamental dimensions of schizophrenia[3,4]. Bleuler also believed that the thought disorders found in schizophrenia mirrored the condensation, displacement and symbolic distortions that characterize dreams and nightmares[5].

Almost everyone experiences nightmares occasionally, and they are especially commonplace in childhood. About 50%-60% of children aged 5 to 10 years have frequent nightmares[6] and approximately 2.5% of these children continue to have nightmares after the age of 10[7]. Prevalence studies in adults report that from 2% to 6% of the general population have frequent (one or more per week) nightmares[8,9], but that the prevalence is higher in psychiatric patients[8,10,11].


In the context of schizophrenia, approximately 10% of persons with this diagnosis have been reported to experience frequent nightmares[12]. Some reports place the prevalence from somewhat to substantially higher in schizophrenia[13]. Although frequency is important, it is the distress of the nightmares that predicts both psychopathology and day time function[14] because nightmares interfere with restorative sleep and because the distress experienced at night carries over to the day.

Compared to bad dreams, nightmares are more bizarre or outlandish; they usually involve violence, and the narrative almost always ends in failure and misfortune for the dreamer. The usual reaction to nightmares is terror[15]. For reasons of personality traits or past experience, some individuals are more at risk than others, both for nightmare frequency and for the resulting distress[16]. What is clinically worrisome is that, even when a person with a diagnosis of psychotic illness reports the disturbing occurrence of nightmares (which they do not do unless specifically asked), it is rarely addressed in therapy. This is in marked contrast to the deliberate clinical targeting of nightmares when reported by persons with a diagnosis of posttraumatic stress syndrome. Nightmares need to be addressed in the context of schizophrenia for three main reasons. Firstly, they can be early warning signs of impending psychotic illness requiring early intervention[17,18]. Secondly, they often signal increased delusional severity as well as cognitive decline and, therefore, may require treatment reconsideration[12]. Thirdly, there is a strong association between nightmares and suicide, which demands serious attention[19-23].


The first step toward treatment is always to inquire about bad dreams and nightmares during the initial assessment, and subsequently during follow up visits. Whenever these are endorsed, the next step is a drug screen because it is possible that drugs utilized to treat the patient are promoting the induction of nightmares[24,25]. The drugs that tend to do so fall into several main categories: Hypnotics, beta blockers, statins, dopamine agonists, anti-epileptics, antibiotics, and antidepressants. Anti-epileptics and antidepressants are frequently used to treat persons with psychosis and should be re-evaluated in the presence of nightmares. The most common agents used to treat psychosis are, of course, antipsychotic drugs, which, while able to dampen arousing dream content[26], have not, in general, been found effective for reducing the distress of nightmares, nor for lowering their frequency.

There are specific treatments that have been found effective for nightmares in the non-psychotic population and these are: (1) Relaxation (instructions about relaxing and practice exercises in breathing); (2) Recording (encouraging the writing out of the details of nightmares); (3) Imaginal exposure (deliberately reliving the nightmare in one’s imagination); (4) Imagery rehearsal (deliberately changing the script of recurring nightmares, providing happy endings and frequently rehearsing the rewritten script); and (5) Lucid dreaming (learning to become aware during a nightmare that one is dreaming and then changing the script of the nightmare while still dreaming[27-31]. Lucid dreaming is interesting because neural correlates of lucid dreaming and of insight deficits in psychosis show striking overlap; fronto-parietal regions are involved in both phenomena[32].

Several specific pharmacological treatments for nightmares have also been evaluated. Prazosin, an anti-alpha adrenergic agent, has shown most evidence of efficacy[33-35]. Thus far, the therapies for nightmares with the most evidence to support their use are prazosin and Image Rehearsal Therapy (IRT)[35-37]. For those interested in understanding the procedure of IRT, I refer the reader to a very helpful online guide[38].

Specifically in reference to patients with psychosis, IRT has been successfully used for nightmares in inpatient psychiatric settings, but patients with psychosis were excluded from these studies on the assumption that they would not be able to follow instructions[39-41]. These studies do show, however, that IRT can be used safely and effectively in psychiatric hospital environments where patients tend to be severely ill. Sheaves et al[42] treated 5 patients with psychosis with IRT, too small a number to demonstrate effectiveness, but sufficient to show acceptability and feasibility.

The caveats of this approach are that effective treatment of nightmares has not yet been convincingly demonstrated in individuals with psychosis, nor is there evidence that the alleviation of nightmares will reduce psychotic symptoms. On the other hand, psychotic patients are known to respond well to cognitive behavior therapies for other sleep conditions, such as insomnia[43,44], so the chances are that they will be able to respond equally well to nightmare therapies. Nightmares in this population may also respond to post traumatic stress disorder (PTSD) therapies since rapid eye movement (REM) sleep interruption correlates with nightmare complaints caused by stress[45].

Patients with psychosis themselves claim that treatment of sleep problems has a positive impact on many aspects of their lives[46]. The better their sleep is, the milder their psychotic symptoms. And vice versa: The less they suffer from psychotic symptoms during the day, the better they are able to sleep[39].

Clinicians also recognize the link, but the treatment of sleep disturbances in this population continues to be limited[47,48]. On the whole, mental healthcare providers are not well informed about the consequences of nightmares nor do they know about available treatment options[49,50]. Patients may underreport nightmares and rarely seek treatment for them, considering them irrelevant to their main concerns[51]. Mental healthcare practitioners may consider sleep problems as mere accessories to a larger psychiatric condition, and, thus, not requiring specific attention[52]. This is a missed opportunity because IRT has been shown to be an effective treatment for nightmares in other populations[40,53] and should be considered at an early stage of psychotic illness, as an adjunct to standard mental health treatment.


Manuscript source: Invited manuscript

Specialty type: Psychiatry

Country of origin: Canada

Peer-review report classification

Grade A (Excellent): A, A

Grade B (Very good): B

Grade C (Good): 0

Grade D (Fair): 0

Grade E (Poor): 0

P- Reviewer: Chakrabarti S, Gazdag G, Pasquini M S- Editor: Ji FF L- Editor: A E- Editor: Bian YN

1.  Limosani I, D’Agostino A, Manzone ML, Scarone S. The dreaming brain/mind, consciousness and psychosis. Conscious Cogn. 2011;20:987-992.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 12]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
2.  D’Agostino A, Aletti G, Carboni M, Cavallotti S, Limosani I, Manzone M, Scarone S. Are delusional contents replayed during dreams? Conscious Cogn. 2013;22:708-715.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in F6Publishing: 8]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
3.  Rossi Monti M, Stanghellini G. Influencing and being influenced: the other side of ‘bizarre delusions’. 1. Analysis of the concept. Psychopathology. 1993;26:159-164.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 5]  [Cited by in F6Publishing: 6]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]
4.  Stanghellini G, Rossi Monti M. Influencing and being influenced: the other side of ‘bizarre delusions’. 2. Clinical investigation. Psychopathology. 1993;26:165-169.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 13]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
5.  Dalzell TG. Eugen Bleuler 150: Bleuler’s reception of Freud. Hist Psychiatry. 2007;18:471-482.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14]  [Cited by in F6Publishing: 8]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
6.  Schredl M, Fricke-Oerkermann L, Mitschke A, Wiater A, Lehmkuhl G. Longitudinal study of nightmares in children: stability and effect of emotional symptoms. Child Psychiatry Hum Dev. 2009;40:439-449.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 54]  [Cited by in F6Publishing: 56]  [Article Influence: 4.0]  [Reference Citation Analysis (0)]
7.  Gauchat A, Séguin JR, Zadra A. Prevalence and correlates of disturbed dreaming in children. Pathol Biol (Paris). 2014;62:311-318.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 15]  [Cited by in F6Publishing: 8]  [Article Influence: 0.9]  [Reference Citation Analysis (0)]
8.  Li SX, Zhang B, Li AM, Wing YK. Prevalence and correlates of frequent nightmares: a community-based 2-phase study. Sleep. 2010;33:774-780.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 99]  [Cited by in F6Publishing: 105]  [Article Influence: 8.1]  [Reference Citation Analysis (0)]
9.  Sandman N, Valli K, Kronholm E, Ollila HM, Revonsuo A, Laatikainen T, Paunio T. Nightmares: Prevalence among the Finnish General Adult Population and War Veterans during 1972-2007. Sleep. 2013;36:1041-1050.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 71]  [Cited by in F6Publishing: 78]  [Article Influence: 7.8]  [Reference Citation Analysis (0)]
10.  Sandman N, Valli K, Kronholm E, Revonsuo A, Laatikainen T, Paunio T. Nightmares: risk factors among the Finnish general adult population. Sleep. 2015;38:507-514.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 46]  [Cited by in F6Publishing: 49]  [Article Influence: 6.1]  [Reference Citation Analysis (0)]
11.  Swart ML, van Schagen AM, Lancee J, van den Bout J. Prevalence of nightmare disorder in psychiatric outpatients. Psychother Psychosom. 2013;82:267-268.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 58]  [Cited by in F6Publishing: 62]  [Article Influence: 6.9]  [Reference Citation Analysis (0)]
12.  Sheaves B, Onwumere J, Keen N, Stahl D, Kuipers E. Nightmares in Patients With Psychosis: The Relation With Sleep, Psychotic, Affective, and Cognitive Symptoms. Can J Psychiatry. 2015;60:354-361.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 47]  [Cited by in F6Publishing: 45]  [Article Influence: 5.6]  [Reference Citation Analysis (0)]
13.  Mume CO. Nightmares in schizophrenic and depressed patients. Eur J Psychiatry. 2009;23:177-183.  [PubMed]  [DOI]  [Cited in This Article: ]
14.  Chiu VW, Ree M, Janca A, Waters F. Sleep in Schizophrenia: Exploring Subjective Experiences of Sleep Problems, and Implications for Treatment. Psychiatr Q. 2016;87:633-648.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 34]  [Cited by in F6Publishing: 33]  [Article Influence: 4.7]  [Reference Citation Analysis (0)]
15.  Robert G, Zadra A. Thematic and content analysis of idiopathic nightmares and bad dreams. Sleep. 2014;37:409-417.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 48]  [Cited by in F6Publishing: 50]  [Article Influence: 5.6]  [Reference Citation Analysis (0)]
16.  Rek S, Sheaves B, Freeman D. Nightmares in the general population: identifying potential causal factors. Soc Psychiatry Psychiatr Epidemiol. 2017;52:1123-1133.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 28]  [Cited by in F6Publishing: 28]  [Article Influence: 4.7]  [Reference Citation Analysis (0)]
17.  Fisher HL, Lereya ST, Thompson A, Lewis G, Zammit S, Wolke D. Childhood parasomnias and psychotic experiences at age 12 years in a United Kingdom birth cohort. Sleep. 2014;37:475-482.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 48]  [Cited by in F6Publishing: 52]  [Article Influence: 5.8]  [Reference Citation Analysis (0)]
18.  Thompson A, Lereya ST, Lewis G, Zammit S, Fisher HL, Wolke D. Childhood sleep disturbance and risk of psychotic experiences at 18: UK birth cohort. Br J Psychiatry. 2015;207:23-29.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 40]  [Cited by in F6Publishing: 43]  [Article Influence: 5.4]  [Reference Citation Analysis (0)]
19.  Bernert RA, Kim JS, Iwata NG, Perlis ML. Sleep disturbances as an evidence-based suicide risk factor. Curr Psychiatry Rep. 2015;17:554.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 221]  [Cited by in F6Publishing: 232]  [Article Influence: 29.0]  [Reference Citation Analysis (0)]
20.  Nadorff MR, Pearson MD, Golding S. Explaining the Relation between Nightmares and Suicide. J Clin Sleep Med. 2016;12:289-290.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in F6Publishing: 8]  [Article Influence: 1.1]  [Reference Citation Analysis (0)]
21.  Pigeon WR, Pinquart M, Conner K. Meta-analysis of sleep disturbance and suicidal thoughts and behaviors. J Clin Psychiatry. 2012;73:e1160-e1167.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 484]  [Cited by in F6Publishing: 491]  [Article Influence: 44.6]  [Reference Citation Analysis (1)]
22.  Sandman N, Valli K, Kronholm E, Vartiainen E, Laatikainen T, Paunio T. Nightmares as predictors of suicide: an extension study including war veterans. Sci Rep. 2017;7:44756.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 29]  [Cited by in F6Publishing: 33]  [Article Influence: 5.5]  [Reference Citation Analysis (0)]
23.  Titus CE, Speed KJ, Cartwright PM, Drapeau CW, Heo Y, Nadorff MR. What role do nightmares play in suicide? A brief exploration. Curr Opin Psychol. 2018;22:59-62.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 16]  [Cited by in F6Publishing: 14]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]
24.  Pagel JF, Helfter P. Drug induced nightmares--an etiology based review. Hum Psychopharmacol. 2003;18:59-67.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 89]  [Cited by in F6Publishing: 88]  [Article Influence: 4.4]  [Reference Citation Analysis (0)]
25.  Thompson DF, Pierce DR. Drug-induced nightmares. Ann Pharmacother. 1999;33:93-98.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 81]  [Cited by in F6Publishing: 86]  [Article Influence: 3.6]  [Reference Citation Analysis (0)]
26.  Lusignan FA, Zadra A, Dubuc MJ, Daoust AM, Mottard JP, Godbout R. Dream content in chronically-treated persons with schizophrenia. Schizophr Res. 2009;112:164-173.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 29]  [Cited by in F6Publishing: 32]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]
27.  Harb GC, Brownlow JA, Ross RJ. Posttraumatic nightmares and imagery rehearsal: The possible role of lucid dreaming. Dreaming. 2016;26:238-249.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 19]  [Cited by in F6Publishing: 19]  [Article Influence: 2.7]  [Reference Citation Analysis (0)]
28.  Holzinger B, Klösch G, Saletu B. Studies with lucid dreaming as add-on therapy to Gestalt therapy. Acta Neurol Scand. 2015;131:355-363.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 31]  [Cited by in F6Publishing: 34]  [Article Influence: 4.3]  [Reference Citation Analysis (0)]
29.  Krakow B, Zadra A. Clinical management of chronic nightmares: imagery rehearsal therapy. Behav Sleep Med. 2006;4:45-70.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 175]  [Cited by in F6Publishing: 179]  [Article Influence: 10.5]  [Reference Citation Analysis (0)]
30.  Lancee J, Spoormaker VI, Krakow B, van den Bout J. A systematic review of cognitive-behavioral treatment for nightmares: toward a well-established treatment. J Clin Sleep Med. 2008;4:475-480.  [PubMed]  [DOI]  [Cited in This Article: ]
31.  Lancee J, van den Bout J, Spoormaker VI. Expanding self-help Imagery Rehearsal Therapy for nightmares with sleep hygiene and lucid dreaming: a waiting-list controlled trial. Int J Dream Research. 2010;3:111-120.  [PubMed]  [DOI]  [Cited in This Article: ]
32.  Dresler M, Wehrle R, Spoormaker VI, Steiger A, Holsboer F, Czisch M, Hobson JA. Neural correlates of insight in dreaming and psychosis. Sleep Med Rev. 2015;20:92-99.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 39]  [Cited by in F6Publishing: 30]  [Article Influence: 3.3]  [Reference Citation Analysis (0)]
33.  Augedal AW, Hansen KS, Kronhaug CR, Harvey AG, Pallesen S. Randomized controlled trials of psychological and pharmacological treatments for nightmares: a meta-analysis. Sleep Med Rev. 2013;17:143-152.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 56]  [Cited by in F6Publishing: 61]  [Article Influence: 5.5]  [Reference Citation Analysis (0)]
34.  Raskind MA, Peterson K, Williams T, Hoff DJ, Hart K, Holmes H, Homas D, Hill J, Daniels C, Calohan J. A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. Am J Psychiatry. 2013;170:1003-1010.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 228]  [Cited by in F6Publishing: 239]  [Article Influence: 23.9]  [Reference Citation Analysis (0)]
35.  Seda G, Sanchez-Ortuno MM, Welsh CH, Halbower AC, Edinger JD. Comparative meta-analysis of prazosin and imagery rehearsal therapy for nightmare frequency, sleep quality, and posttraumatic stress. J Clin Sleep Med. 2015;11:11-22.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 42]  [Cited by in F6Publishing: 43]  [Article Influence: 5.4]  [Reference Citation Analysis (0)]
36.  Aurora RN, Zak RS, Auerbach SH, Casey KR, Chowdhuri S, Karippot A, Maganti RK, Ramar K, Kristo DA, Bista SR. Best practice guide for the treatment of nightmare disorder in adults. J Clin Sleep Med. 2010;6:389-401.  [PubMed]  [DOI]  [Cited in This Article: ]
37.  Casement MD, Swanson LM. A meta-analysis of imagery rehearsal for post-trauma nightmares: effects on nightmare frequency, sleep quality, and posttraumatic stress. Clin Psychol Rev. 2012;32:566-574.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 112]  [Cited by in F6Publishing: 118]  [Article Influence: 10.7]  [Reference Citation Analysis (0)]
38.  Abueg F. A brief guide to imagery rehearsal therapy (IRT) for nightmare disorders for clinicians and patients.  Available from: https://psychcentral.com/blog/a-brief-guide-to-imagery-rehearsal-therapy-irt-for-nightmare-disorders-for-clinicians-and-patients/.  [PubMed]  [DOI]  [Cited in This Article: ]
39.  Ellis TE, Rufino KA, Nadorff MR. Treatment of Nightmares in Psychiatric Inpatients With Imagery Rehearsal Therapy: An Open Trial and Case Series. Behav Sleep Med. 2017;1-14.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 15]  [Cited by in F6Publishing: 18]  [Article Influence: 4.5]  [Reference Citation Analysis (0)]
40.  van Schagen AM, Lancee J, de Groot IW, Spoormaker VI, van den Bout J. Imagery rehearsal therapy in addition to treatment as usual for patients with diverse psychiatric diagnoses suffering from nightmares: a randomized controlled trial. J Clin Psychiatry. 2015;76:e1105-e1113.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 22]  [Cited by in F6Publishing: 23]  [Article Influence: 2.9]  [Reference Citation Analysis (0)]
41.  van Schagen AM, Lancee J, Spoormaker VI, van den Bout J. Long-term treatment effects of imagery rehearsal therapy for nightmares in a population with diverse psychiatric disorders. Int J Dream Res. 2016;9:67-70.  [PubMed]  [DOI]  [Cited in This Article: ]
42.  Sheaves B, Onwumere J, Keen N, Kuipers E. Treating your worst nightmare: a case-series of imagery rehearsal therapy for nightmares in individuals experiencing psychotic symptoms. Cogn Behav Therapist. 2015;8:e27.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 9]  [Cited by in F6Publishing: 9]  [Article Influence: 1.1]  [Reference Citation Analysis (0)]
43.  Freeman D, Waite F, Startup H, Myers E, Lister R, McInerney J, Harvey AG, Geddes J, Zaiwalla Z, Luengo-Fernandez R. Efficacy of cognitive behavioural therapy for sleep improvement in patients with persistent delusions and hallucinations (BEST): a prospective, assessor-blind, randomised controlled pilot trial. Lancet Psychiatry. 2015;2:975-983.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 147]  [Cited by in F6Publishing: 125]  [Article Influence: 15.6]  [Reference Citation Analysis (0)]
44.  Waite F, Myers E, Harvey AG, Espie CA, Startup H, Sheaves B, Freeman D. Treating Sleep Problems in Patients with Schizophrenia. Behav Cogn Psychother. 2016;44:273-287.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 69]  [Cited by in F6Publishing: 62]  [Article Influence: 8.9]  [Reference Citation Analysis (0)]
45.  Habukawa M, Uchimura N, Maeda M, Ogi K, Hiejima H, Kakuma T. Differences in rapid eye movement (REM) sleep abnormalities between posttraumatic stress disorder (PTSD) and major depressive disorder patients: REM interruption correlated with nightmare complaints in PTSD. Sleep Med. 2018;43:34-39.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 22]  [Cited by in F6Publishing: 24]  [Article Influence: 4.0]  [Reference Citation Analysis (1)]
46.  Waite F, Evans N, Myers E, Startup H, Lister R, Harvey AG, Freeman D. The patient experience of sleep problems and their treatment in the context of current delusions and hallucinations. Psychol Psychother. 2016;89:181-193.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 44]  [Cited by in F6Publishing: 45]  [Article Influence: 6.4]  [Reference Citation Analysis (0)]
47.  Kaskie RE, Graziano B, Ferrarelli F. Schizophrenia and sleep disorders: links, risks, and management challenges. Nat Sci Sleep. 2017;9:227-239.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 102]  [Cited by in F6Publishing: 91]  [Article Influence: 15.2]  [Reference Citation Analysis (0)]
48.  Rehman A, Waite F, Sheaves B, Biello S, Freeman D, Gumley A. Clinician perceptions of sleep problems, and their treatment, in patients with non-affective psychosis. Psychosis. 2017;9:129-139.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 26]  [Cited by in F6Publishing: 22]  [Article Influence: 3.1]  [Reference Citation Analysis (0)]
49.  Nadorff MR, Nadorff DK, Germain A. Nightmares: Under-Reported, Undetected, and Therefore Untreated. J Clin Sleep Med. 2015;11:747-750.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 45]  [Cited by in F6Publishing: 54]  [Article Influence: 6.8]  [Reference Citation Analysis (0)]
50.  Thünker J, Norpoth M, von Aspern M, Özcan T, Pietrowsky R. Nightmares: knowledge and attitudes in health care providers and nightmare sufferers. J Pub Health Epidemiol. 2014;6:223-228.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14]  [Cited by in F6Publishing: 14]  [Article Influence: 1.6]  [Reference Citation Analysis (0)]
51.  Schredl M. Seeking professional help for nightmares: a representative study. Eur J Psychiatry. 2013;27:259-264.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 12]  [Article Influence: 1.2]  [Reference Citation Analysis (0)]
52.  O’Sullivan M, Rahim M, Hall C. The prevalence and management of poor sleep quality in a secondary care mental health population. J Clin Sleep Med. 2015;11:111-116.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 9]  [Cited by in F6Publishing: 10]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
53.  Hansen K, Höfling V, Kröner-Borowik T, Stangier U, Steil R. Efficacy of psychological interventions aiming to reduce chronic nightmares: a meta-analysis. Clin Psychol Rev. 2013;33:146-155.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 72]  [Cited by in F6Publishing: 81]  [Article Influence: 7.4]  [Reference Citation Analysis (0)]